Skip to main content
DBD logo
DBD
(NYSE)
Diebold Nixdorf, Incorporated
$77.32-- (--)
Loading... - Market loading

Diebold Nixdorf, Incorporated (DBD) Stock Price & Financial Analysis

Diebold Nixdorf, Incorporated Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$75.71 - $78.23
52-Week High$84.46
52-Week Low$34.88
Open$75.71
Volume129.00K
Average Volume (3M)129.00K
Market Cap2.81B
Shares Outstanding36.30M
P/E Ratio (TTM)29.80
Price to Sales (P/S)0.74
Price to Book (P/B)2.56
EV/EBITDA10.17
Revenue (TTM)3.81B
Net Income (TTM)94.60M
Free Cash Flow (TTM)239.00M
EPS (TTM)$2.61
Profit Margin2.49%
Operating Margin6.70%
Return on Equity (ROE)8.60%
Debt to Equity0.90
50-Day MA$75.01
200-Day MA$64.44
52-Week Change76.14%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateFeb 23, 2018

Frequently Asked Questions About Diebold Nixdorf, Incorporated

What is the current stock price for DBD?

As of the latest trading session, DBD stock trades at $77.32. The 52-week range is $34.88–$84.46, with a day range of $75.71–$78.23.

What is the P/E ratio for DBD?

Diebold Nixdorf, Incorporated's trailing P/E ratio is 29.8, meaning investors pay $29.8 for every $1 of annual earnings. Diebold Nixdorf, Incorporated operates in the Technology sector.

Does DBD pay dividends?

Diebold Nixdorf, Incorporated does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DBD?

Based on 2 analysts, the consensus for DBD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of DBD?

Diebold Nixdorf, Incorporated's market capitalization is $2.81B, classifying it as a mid-cap company. Diebold Nixdorf, Incorporated operates in the Technology sector within the Software - Application industry.